Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Zeev's Turnips - No Politics -- Ignore unavailable to you. Want to Upgrade?

To: Softechie who wrote (67767)	5/15/2002 4:23:09 PM
From: GREENLAW4-7	Read Replies (3) \| Respond to of 99280

BRCD will see 18-19 tomorrow..on deferred revenues

To: Softechie who wrote (67767)	5/15/2002 4:31:50 PM
From: LTK007	Respond to of 99280

My comment on SGP on Mar24 <<From: itsallover Sunday, Mar 24, 2002 6:07 PM Respond to of 67769 Problem number one is profit margin on Claritin OTC is expected to be 10% of prescription Claritin. That's a problem Plus, to be frank i don't like this company. The WSJ article paints a dark picture. It's past history stinks.>> point of reposting this, if i am good at anything in stocks, it's getting the feel for just plain rotten companies. And news today is bringing it on home regards Schering, this company is both corrupt and incompetent.WJS is saying this is more serious than just FDA regulation hand slaps, there is a real chance they are to be hit with criminal charges. Max